Functional Activation of ATM by the Prostate Cancer Suppressor NKX3.1

被引:36
|
作者
Cai Bowen [1 ,2 ]
Ju, Jeong-Ho [1 ,2 ]
Lee, Ji-Hoon [3 ,4 ,5 ]
Paull, Tanya T. [3 ,4 ,5 ]
Gelmann, Edward P. [1 ,2 ]
机构
[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Dept Pathol, New York, NY 10032 USA
[3] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA
[4] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA
[5] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA
来源
CELL REPORTS | 2013年 / 4卷 / 03期
关键词
DNA-DAMAGE RESPONSE; BASE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; TOPOISOMERASE-I; PROTEIN-KINASE; EXPRESSION; PHOSPHORYLATION; GENOME; GENE; AUTOPHOSPHORYLATION;
D O I
10.1016/j.celrep.2013.06.039
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prostate tumor suppressor NKX3.1 augments response to DNA damage and enhances survival after DNA damage. Within minutes of DNA damage, NKX3.1 undergoes phosphorylation at tyrosine 222, which is required for a functional interaction with ataxia telangiectasia mutated (ATM) kinase. NKX3.1 binds to the N-terminal region of ATM, accelerates ATM activation, and hastens the formation of gamma histone2AX. NKX3.1 enhances DNA-dependent ATM kinase activation by both the MRN complex and H2O2 in a DNA-damage-independent manner. ATM, bound to the NKX3.1 homeodomain, phosphorylates NKX3.1, leading to ubiquitination and degradation. Thus, NKX3.1 and ATM have a functional interaction leading to ATM activation and then NKX3.1 degradation in a tightly regulated DNA damage response specific to prostate epithelial cells. These findings demonstrate a mechanism for the tumor-suppressor properties of NKX3.1, demonstrate how NKX3.1 may enhance DNA integrity in prostate stem cells and may help to explain how cells differ in their sensitivity to DNA damage.
引用
收藏
页码:516 / 529
页数:14
相关论文
共 50 条
  • [31] Gene of the month: NKX3.1
    Griffin, Jon
    Chen, Yuqing
    Catto, James W. F.
    El-Khamisy, Sherif
    JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (06) : 361 - 364
  • [32] Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis
    Shen, MM
    Abate-Shen, C
    DEVELOPMENTAL DYNAMICS, 2003, 228 (04) : 767 - 778
  • [33] Nkx3.1 controls the DNA repair response in the mouse prostate
    Zhang, Hailan
    Zheng, Tian
    Chua, Chee Wai
    Shen, Michael
    Gelmann, Edward P.
    PROSTATE, 2016, 76 (04): : 402 - 408
  • [34] RNA interference reveals new functions of NKX3.1 in LNCAP prostate cancer cells
    Thelen, Paul
    Possner, Maria
    Kaulfuss, Silke
    Ringert, Rolf-Hermann
    JOURNAL OF UROLOGY, 2008, 179 (04): : 421 - 421
  • [35] NKX3.1 Expression Contributes to Epithelial-Mesenchymal Transition of Prostate Cancer Cells
    Saydullaeva, Iroda
    Butuner, Bilge Debelec
    Korkmaz, Kemal Sami
    ACS OMEGA, 2023, 8 (36): : 32580 - 32592
  • [36] Interaction of NKX3.1 genotype and IGF-1 affect prostate cancer risk
    Asatiani, Ekaterina
    Ortner, Elizabeth
    Muhlbradt, Erin E.
    Li, Haojie
    Ma, Jing
    Gelmann, Edward P.
    Stampfer, Meir
    CANCER RESEARCH, 2006, 66 (08)
  • [37] Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis
    Song, H.
    Zhang, B.
    Watson, M. A.
    Humphrey, P. A.
    Lim, H.
    Milbrandt, J.
    ONCOGENE, 2009, 28 (37) : 3307 - 3319
  • [38] Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis
    H Song
    B Zhang
    M A Watson
    P A Humphrey
    H Lim
    J Milbrandt
    Oncogene, 2009, 28 : 3307 - 3319
  • [39] Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer
    Xu, LL
    Srikantan, V
    Sesterhenn, IA
    Augustus, M
    Dean, R
    Moul, JW
    Carter, KC
    Srivastava, S
    JOURNAL OF UROLOGY, 2000, 163 (03): : 972 - 979
  • [40] Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis
    Kim, MJ
    Bhatia-Gaur, R
    Banach-Petrosky, WA
    Desai, N
    Wang, YZ
    Hayward, SW
    Cunha, GR
    Cardiff, RD
    Shen, MM
    Abate-Shen, C
    CANCER RESEARCH, 2002, 62 (11) : 2999 - 3004